Background Disruption of granulocyte/macrophage colony-stimulating factor (GM-CSF) signalling causes pulmonary alveolar proteinosis (PAP). Rarely, genetic defects in neonatal or infant-onset PAP have been identified in CSF2RA. However, no report has clearly identified any function-associated genetic defect in CSF2RB. Methods and results The patient was diagnosed with PAP at the age of 36 and developed respiratory failure. She was negative for GM-CSF autoantibody and had no underlying disease. Signalling and genetic defects in GM-CSF receptor were screened. GM-CSF-stimulated STAT5 phosphorylation was not observed and GM-CSF-Rβc expression was defective in the patient\u27s blood cells. Genetic screening revealed a homozygous, single-base dele...
Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of a surfactant-like substance...
AbstractMice deficient in granulocyte-macrophage colony stimulating factor (GM-CSF) develop pulmonar...
Pulmonary alveolar proteinosis is a rare clinical syndrome that was first described in 1958. Subsequ...
Background Disruption of granulocyte/macrophage colony-stimulating factor (GM-CSF) signalling causes...
We identified a 6-year-old girl with pulmonary alveolar proteinosis (PAP), impaired granulocyte-macr...
Background: Juvenile pulmonary alveolar proteinosis (PAP) due to CSF2RA mutations is a rare disorder...
AbstractHereditary pulmonary alveolar proteinosis (PAP) caused by mutations in CSF2RA or CSF2RB, whi...
Background: Clinical presentation, diagnosis, management and outcome of molecularly defined congenit...
Hereditary pulmonary alveolar proteinosis (PAP) caused by mutations in CSF2RA or CSF2RB, which encod...
BackgroundJuvenile pulmonary alveolar proteinosis (PAP) due to CSF2RA mutations is a rare disorder w...
Background The majority of cases with severe pulmonary alveolar proteinosis (PAP) are caused by aut...
Background Juvenile pulmonary alveolar proteinosis (PAP) due to CSF2RA mutations is a rare disorder ...
The pathogenesis of acquired pulmonary alveolar proteinosis (PAP), a rare lung disease characterized...
Pulmonary alveolar proteinosis (PAP) is a heterogenous dis-order of genetic or acquired etiologies. ...
Pulmonary Alveolar Proteinosis (PAP) is a rare lung disease characterized by excessive accumulation ...
Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of a surfactant-like substance...
AbstractMice deficient in granulocyte-macrophage colony stimulating factor (GM-CSF) develop pulmonar...
Pulmonary alveolar proteinosis is a rare clinical syndrome that was first described in 1958. Subsequ...
Background Disruption of granulocyte/macrophage colony-stimulating factor (GM-CSF) signalling causes...
We identified a 6-year-old girl with pulmonary alveolar proteinosis (PAP), impaired granulocyte-macr...
Background: Juvenile pulmonary alveolar proteinosis (PAP) due to CSF2RA mutations is a rare disorder...
AbstractHereditary pulmonary alveolar proteinosis (PAP) caused by mutations in CSF2RA or CSF2RB, whi...
Background: Clinical presentation, diagnosis, management and outcome of molecularly defined congenit...
Hereditary pulmonary alveolar proteinosis (PAP) caused by mutations in CSF2RA or CSF2RB, which encod...
BackgroundJuvenile pulmonary alveolar proteinosis (PAP) due to CSF2RA mutations is a rare disorder w...
Background The majority of cases with severe pulmonary alveolar proteinosis (PAP) are caused by aut...
Background Juvenile pulmonary alveolar proteinosis (PAP) due to CSF2RA mutations is a rare disorder ...
The pathogenesis of acquired pulmonary alveolar proteinosis (PAP), a rare lung disease characterized...
Pulmonary alveolar proteinosis (PAP) is a heterogenous dis-order of genetic or acquired etiologies. ...
Pulmonary Alveolar Proteinosis (PAP) is a rare lung disease characterized by excessive accumulation ...
Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of a surfactant-like substance...
AbstractMice deficient in granulocyte-macrophage colony stimulating factor (GM-CSF) develop pulmonar...
Pulmonary alveolar proteinosis is a rare clinical syndrome that was first described in 1958. Subsequ...